MEDIFAST, INC.— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$248M
↓-12.8% -$36Mvs FY2024
Total Liabilities
$49M
↓-33.8% -$25Mvs FY2024
Equity
$199M
↓-5.3% -$11Mvs FY2024
Cash
$89M
↓-1.8% -$2Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $248M | $284M |
| Current Assets | $202M | $214M |
| Cash | $89M | $91M |
| ST Investments | $78M | $71M |
| Receivables | $0 | $0 |
| Inventory | $20M | $42M |
| Other Current | $14M | $10M |
| Non-Current Assets | $46M | $70M |
| PPE | $31M | $38M |
| Goodwill | $0 | $0 |
| Intangibles | $0 | $0 |
| Investments | $0 | $0 |
| Other Non-Current | $15M | $32M |
| Total Liab+Eq | $248M | $284M |
| Current Liab. | $43M | $64M |
| Accounts Payable | $0 | $0 |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $384K | $316K |
| Other CL | $43M | $64M |
| Non-Current Liab. | $6M | $10M |
| Long-Term Debt | $0 | $0 |
| Other LT Liab. | $6M | $10M |
| Equity | $199M | $210M |
| Retained Earnings | $158M | $177M |
| Other Equity | $41M | $33M |
QuarterCharts · SEC EDGAR data · MED · Comparing FY2025 vs FY2024